These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8720064

  • 1. The feline herpesvirus type 1 ICP4 down-regulates feline immunodeficiency virus long terminal repeat (LTR)-directed gene expression via the C/EBP site in the LTR.
    Kawaguchi Y, Maeda K, Pecoraro MR, Inoshima Y, Jang HK, Kohmoto M, Iwatsuki K, Ikeda Y, Shimojima M, Tohya Y.
    J Vet Med Sci; 1995 Dec; 57(6):1129-31. PubMed ID: 8720064
    [Abstract] [Full Text] [Related]

  • 2. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y, Tomonaga K, Maeda K, Ono M, Miyazawa T, Kohmoto M, Tohya Y, Mikami T.
    Virology; 1995 Apr 20; 208(2):492-9. PubMed ID: 7747422
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Sparger EE, Shacklett BL, Renshaw-Gegg L, Barry PA, Pedersen NC, Elder JH, Luciw PA.
    Virology; 1992 Mar 20; 187(1):165-77. PubMed ID: 1310554
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.
    Kawaguchi Y, Norimine J, Miyazawa T, Kai C, Mikami T.
    Virology; 1992 Sep 20; 190(1):465-8. PubMed ID: 1326814
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1.
    Kawaguchi Y, Miyazawa T, Horimoto T, Itagaki S, Fukasawa M, Takahashi E, Mikami T.
    Virology; 1991 Sep 20; 184(1):449-54. PubMed ID: 1651603
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the feline herpesvirus type 1 immediate early gene expression.
    Kawaguchi Y, Maeda K, Ono M, Yokoyama N, Tsubota K, Fujita K, Tohya Y, Kai C, Mikami T.
    J Vet Med Sci; 1996 Aug 20; 58(8):715-21. PubMed ID: 8877967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
    Bigornia L, Lockridge KM, Sparger EE.
    J Virol; 2001 Jan 20; 75(2):1054-60. PubMed ID: 11134320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D, Alam J, Prakash O.
    J Mol Neurosci; 2001 Jan 20; 5(4):241-58. PubMed ID: 7577367
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.